EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

HDAC inhibitors as ferroptosis sensitizers in cancer: Epigenetic regulation of redox balance and iron metabolism

Mubarak A Alamri, Muhammad Afzal, Surya Nath Pandey, Obaid Afzal, Mohamed Ahmed Akela, A Rekha

EXCLI Journal · 08.07.2026 · 25 · 1014-1036

DOI: 10.17179/excli2026-9414 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift EXCLI Journal, online erschienen am 08.07.2026. Verfasst von Mubarak A Alamri und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Chemistry, College of Pharmacy, Prince Sattam bin Abdulaziz University, Al-Kharj 11942, Saudi Arabia. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The evasion of programmed cell death significantly contributes to therapeutic failure in cancer, with resistance to apoptosis being the most prevalent form of resistance in multidrug-refractory diseases. Ferroptosis, an iron-dependent, non-apoptotic form of regulated cell death characterized by the lethal accumulation of lipid peroxides, represents a pharmacologically significant vulnerability in cancers that are resistant to apoptosis and tolerant to drugs. The resistance to ferroptosis, induced by the aberrant overexpression of the epigenetic enzyme histone deacetylases (HDACs) and the sustained transcriptional activity of key antiferroptotic targets, particularly GPX4 and SLC7A11, is enforced through epigenetic mechanisms. This review examines the extant preclinical and translational data, demonstrating that HDAC inhibitors predispose cancer cells to ferroptosis through four mechanistically convergent pathways. These pathways include the transcriptional silencing of SLC7A11 and subsequent glutathione depletion, disruption of intracellular iron homeostasis via ferroportin downregulation, enhancement of mitochondrial ROS-induced lipid peroxidation, and suppression of the HDAC3–NRF2–GPX4 antiferroptotic axis. The specific roles of HDAC1, HDAC3, and HDAC10 in colorectal, lung, gastric, and hematological cancers are elucidated. Additionally, the review discusses hybrid molecules of HDAC-ferroptosis, combination strategies with GPX4 inhibitors, and immunochemotherapy. Considerations such as isoform selectivity, biomarker development, and clinical translation are addressed, highlighting HDAC inhibitor-mediated ferroptosis sensitization as a promising strategy to overcome drug resistance in cancer.

Schlagwörter

Stichwörter der Autor:innen

GPX4SLC7A11epigenetic regulationferroptosishistone deacetylase inhibitorsiron metabolism

Autor:innen und Institutionen

  • Department of Pharmaceutical Chemistry, College of Pharmacy, Prince Sattam bin Abdulaziz University, Al-Kharj 11942, Saudi Arabia.
  • Department of Pharmaceutical Sciences, Pharmacy Program, Batterjee Medical College, Jeddah 21442, Saudi Arabia.
  • Department of Pharmacology, Teerthanker Mahaveer College of Pharmacy, Teerthanker Mahaveer University, Moradabad 244001 Uttar Pradesh, India.
  • Department of Biology, College of Science and Humanities in Al-Kharj, Prince Sattam bin Abdulaziz University, Al-Kharj 11942, Saudi Arabia.
  • Dr DY Patil Medical College, Hospital and Research Centre, Pimpri, Pune 411018, India.

Zitieren

APA

Alamri, M. A., Afzal, M., Pandey, S. N., Afzal, O., Akela, M. A., & Rekha, A. (2026). HDAC inhibitors as ferroptosis sensitizers in cancer: Epigenetic regulation of redox balance and iron metabolism. EXCLI Journal, 25, 1014-1036. https://doi.org/10.17179/excli2026-9414

Vancouver

Alamri MA, Afzal M, Pandey SN, Afzal O, Akela MA, Rekha A. HDAC inhibitors as ferroptosis sensitizers in cancer: Epigenetic regulation of redox balance and iron metabolism. EXCLI Journal. 2026;25:1014-1036. doi:10.17179/excli2026-9414

BibTeX
@article{Alamri2026,
  author = {Alamri, Mubarak A and Afzal, Muhammad and Pandey, Surya Nath and Afzal, Obaid and Akela, Mohamed Ahmed and Rekha, A},
  title = {HDAC inhibitors as ferroptosis sensitizers in cancer: Epigenetic regulation of redox balance and iron metabolism},
  journal = {EXCLI Journal},
  year = {2026},
  volume = {25},
  pages = {1014--1036},
  doi = {10.17179/excli2026-9414}
}
Kostenlos starten →